Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney
General of Louisiana, Charles C. Foti, Jr., remind investors that they
have until February 2, 2015 to file lead plaintiff applications
in a securities class action lawsuit against Sanofi (NYSE: SNY) if they
purchased the Company’s securities between February 7, 2013 and December
3, 2014, inclusive (the “Class Period”). This action is pending in the
United States District Court for the Southern District of New York.
What You May Do
If you purchased shares of Sanofi and would like to discuss your legal
rights and how this case might affect you and your right to recover for
your economic loss, you may, without obligation or cost to you, call
toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com).
If you wish to serve as a lead plaintiff in this class action, you must
petition the Court by February 2, 2015.
About the Lawsuit
Sanofi and certain of its executives are charged with failing to
disclose material information during the Class Period, violating federal
securities laws.
On October 6, 2014, Sanofi announced that it was investigating
allegations related to improper payments to healthcare workers.
Following that announcement, on October 29, 2014, Sanofi disclosed that
it had terminated its CEO Christopher A. Viehbacher. Then, on December
3, 2014, it was reported that a whistleblower lawsuit against Sanofi was
filed by a former paralegal alleging that Viehbacher and other Sanofi
executives conducted a scheme in violation of federal law to funnel tens
of millions of dollars in kickbacks and other incentives to get the
company’s diabetes drugs prescribed and sold. The lawsuit also alleges
that Viehbacher was fired in part because he was involved in the
kickback scheme.
Following this news, Safoni’s stock price plummeted.
About Kahn Swick & Foti, LLC
To learn more about KSF, whose partners include the Former Louisiana
Attorney General, Charles C. Foti, Jr., and other lawyers with
significant experience litigating complex securities class actions
nationwide on behalf of both institutional and individual shareholders,
you may visit www.ksfcounsel.com.
Copyright Business Wire 2015